COLL Overview

Company Profile

Related stocks

ESPR • United States

Esperion Therapeutics, Inc.

3.18 USD

819.46M USD

AMPH • United States

Amphastar Pharmaceuticals, Inc.

26.62 USD

1.13B USD 1Y -0.7%

IRWD • United States

Ironwood Pharmaceuticals, Inc.

3.82 USD

631.22M USD 1Y +144.9%

ETON • United States

Eton Pharmaceuticals, Inc.

55.21 USD

1.58B USD 1Y +161.6%

GTII.CN • United States

GreenThumb

9.58 CAD

1.47B USD 1Y -21.2%

XERS • United States

Xeris Biopharma Holdings, Inc.

10.48 USD

1.91B USD 1Y +24.3%

ANIP • United States

ANI Pharmaceuticals, Inc.

73.89 USD

1.7B USD 1Y -21.5%

PAHC • United States

Phibro Animal Health Corporatio

38.3 USD

1.56B USD 1Y +0.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

United States

Region

North America

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

40.6% p.a.

Max Drawdown (5Y)

-56.2%

Sharpe Ratio (5Y)

-0.02

Beta Factor

0.73

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 390%.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -65.2% in the extended horizon.